Sitamarc Dp 10/100 Tab

Tablet

Type 2 diabetes mellitus (as an add-on to diet and exercise) to improve glycaemic control in adults; may be used when dual therapy is appropriate.

Dapagliflozin is an SGLT2 inhibitor that lowers blood glucose by increasing urinary glucose excretion via the kidneys. Sitagliptin is a DPP-4 inhibitor that increases incretin levels, enhancing glucose-dependent insulin release and reducing glucagon secretion.

Oral tablet. Take once daily as prescribed, preferably at the same time each day, with or without food. Swallow whole with water; maintain adequate hydration and follow diet/exercise advice.

Genital fungal infection,urinary tract infection,increased urination,thirst,dehydration,dizziness,headache,nausea,diarrhoea,nasopharyngitis

Not for type 1 diabetes or diabetic ketoacidosis. Risk of genital/urinary infections and dehydration—drink fluids and seek care for burning urination, fever, or genital symptoms. Monitor kidney function; avoid/ use with caution in moderate-severe renal impairment as per prescriber advice. Rare risks: ketoacidosis (even with normal sugars), pancreatitis (severe abdominal pain), severe allergic reactions, and hypoglycaemia when combined with insulin/sulfonylureas. Temporarily stop before major surgery or during acute illness/fasting as advised by doctor.

Insulin and sulfonylureas (increased hypoglycaemia risk),diuretics (increased dehydration/hypotension risk),rifampicin/phenytoin/carbamazepine/dexamethasone (may reduce sitagliptin effect),digoxin (sitagliptin may increase digoxin levels),other antihyperglycaemics (additive glucose-lowering)

Store below 25°C in a cool, dry place; protect from moisture and direct light. Keep out of reach of children.

Qtern 10/100 Tablet,Forxiga Sitagliptin 10/100 Tablet,DapaSita 10/100 Tablet,Dapglin S 10/100 Tablet,Zita Dapa 10/100 Tablet